English – On-Demand Educational Webinar Series

Upcoming Webinar: Clinical Significance of Ionized Magnesium in Critical Care

Clinical Significance of Ionized Magnesium in Critical Care

Blood gas analyzers are essential devices in point-of-care settings such as respiratory care units, surgical suites, intensive care units, emergency rooms, and the central lab. An advanced menu of tests that includes glucose, lactate, ionized calcium, ionized magnesium, electrolytes, estimated plasma volume, BUN and creatinine along with blood gas provides important results at the point of care. This presentation will discuss the clinical value of having access to an advanced complement of blood test results and the significance of ionized magnesium results in critically ill patients.

Presenter: Jessica Colon-Franco, PhD
Section Head, Clinical Biochemistry Medical Director,
Special Chemistry Department of Laboratory Medicine
Cleveland Clinic

Presenter: Marcin Pacek
Medical and Scientific Affairs Director
Nova Biomedical

Date:

April 10 & April 24

TIme:

1PM EST / 3pm EST

Duration:

1 Hour

Clinical Utility of Ionised Magnesium for Patients in Critical Care

Magnesium, the second most abundant cation in our body and cofactor for over 600 enzymes. It is involved in controlling various important physiological processes such as antiarrhythmic action, vascular tone action, muscle contraction, glucose metabolism and insulin homeostasis. Monitoring blood magnesium levels is usually done by the total magnesium (tMg); however, the physiologically active fraction of the magnesium is the 'ionised magnesium (iMg).'

In this session, Dr Masaru Yamamoto will uncover the key differences between iMg and tMg, review literature on monitoring methods, and their impact on patient outcomes. Leveraging his extensive experience in clinical chemistry and medical affairs, and his distinguished background at Nova Biomedical, Dr Yamamoto will provide valuable insights into the latest research and its clinical implications.

Presenter 1:

Dr Masaru Yamamoto Ph.D.
Director, Asia Pacific, Medical & Scientific Affairs (MASA)
Nova Biomedical

Presenter 2:

Steve Mawditt (Moderator)
National Sales Manager ANZ Nova Biomedical

Date:

6 March 2025

TIme:

Sydney/Melbourne: 5.30PM
Brisbane: 4.30PM
Adelaide: 5.00PM
Perth: 2.30PM
Auckland, NZ: 7.30PM

Duration:

1 Hour

Clinical Utility of Ionised Magnesium for Patients in Critical Care

Magnesium, the second most abundant cation in our body and cofactor for over 600 enzymes. It is involved in controlling various important physiological processes such as antiarrhythmic action, vascular tone action, muscle contraction, glucose metabolism and insulin homeostasis. Monitoring blood magnesium levels is usually done by the total magnesium (tMg); however, the physiologically active fraction of the magnesium is the 'ionised magnesium (iMg).'

In this session, Dr Masaru Yamamoto will uncover the key differences between iMg and tMg, review literature on monitoring methods, and their impact on patient outcomes. Leveraging his extensive experience in clinical chemistry and medical affairs, and his distinguished background at Nova Biomedical, Dr Yamamoto will provide valuable insights into the latest research and its clinical implications.

Presenter 1:

Dr Masaru Yamamoto Ph.D.
Director, Asia Pacific, Medical & Scientific Affairs (MASA)
Nova Biomedical

Presenter 2:

Steve Mawditt
(Moderator) National Sales Manager ANZ
Nova Biomedical

Date:

6 February 2025

TIme:

Sydney/Melbourne: 7.00PM
Brisbane: 6.00PM
Adelaide: 6.30PM
Perth: 4.00PM
Auckland, NZ: 9.00PM

Duration:

1 Hour

Early Blood Glucose Screening in Asymptomatic High-risk Neonates

Detecting and treating severe hypoglycemia promptly after birth is crucial due to its association with adverse long-term neurodevelopmental outcomes. However, limited data are available on the optimal timing of glucose screening in asymptomatic high-risk neonates prone to hypoglycemia. This webinar will address the incidence and the impact of individual risk factors on early hypoglycemia in asymptomatic high-risk neonates. Dr. Hanna will also discuss the importance of blood glucose screening in the first hour of life to help identify early severe neonatal hypoglycemia.

Presenter:
Dr. Nazeeh Hanna, M.D. Professor, Department of Pediatrics at NYU Grossman Long Island School of Medicine Chief, Neonatology, NYU Langone Hospital

Presenter:
Dennis Begos, MD, FACS, FACRS Senior Director Medical and Scientific Affairs Nova Biomedical

Recorded Date:

December 5, 2024

TIme:

1PM - EST

Your cart

Upcoming Webinar: Clinical Significance of Ionized Magnesium in Critical Care

Clinical Utility of Ionised Magnesium for Patients in Critical Care

Presenter 1:

Presenter 2:

Presenter 1:

Presenter 2:

Early Blood Glucose Screening in Asymptomatic High-risk Neonates